Literature DB >> 23767058

Response.

Vikrant V Sahasrabuddhe, Munira Z Gunja, Barry I Graubard, Britton Trabert, Lauren M Schwartz, Yikyung Park, Albert R Hollenbeck, Neal D Freedman, Katherine A McGlynn.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23767058      PMCID： PMC4399434          DOI： 10.1093/jnci/djt063

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  14 in total

1.  Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.

Authors:  Yu-Tse Tsan; Chang-Hsing Lee; Jung-Der Wang; Pau-Chung Chen
Journal:  J Clin Oncol       Date:  2012-01-23       Impact factor: 44.544

Review 2.  A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.

Authors:  J T Cross; E M Poole; C M Ulrich
Journal:  Pharmacogenomics J       Date:  2008-01-15       Impact factor: 3.550

Review 3.  Aspirin chemoprevention of gastrointestinal cancer in the next decade. A review of the evidence.

Authors:  Helena Jankowska; Patricia Hooper; Janusz A Jankowski
Journal:  Pol Arch Med Wewn       Date:  2010-10

4.  Angiotensin converting enzyme inhibitors and hepatocellular carcinoma incidence in the General Practice Research Database.

Authors:  Alex J Walker; Joe West; Matthew J Grainge; Tim R Card
Journal:  Cancer Causes Control       Date:  2011-09-11       Impact factor: 2.506

5.  NSAID activated gene (NAG-1), a modulator of tumorigenesis.

Authors:  Thomas E Eling; Seung Joon Baek; Minsub Shim; Chang Ho Lee
Journal:  J Biochem Mol Biol       Date:  2006-11-30

Review 6.  Aspirin and cancer risk: a quantitative review to 2011.

Authors:  C Bosetti; V Rosato; S Gallus; J Cuzick; C La Vecchia
Journal:  Ann Oncol       Date:  2012-04-19       Impact factor: 32.976

Review 7.  Potential for statins in the chemoprevention and management of hepatocellular carcinoma.

Authors:  Amedeo Lonardo; Paola Loria
Journal:  J Gastroenterol Hepatol       Date:  2012-11       Impact factor: 4.029

Review 8.  Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention.

Authors:  Hang Xiao; Chung S Yang
Journal:  Int J Cancer       Date:  2008-09-01       Impact factor: 7.396

9.  Can propranalol prevent hepatocellular carcinoma?

Authors:  W Thomas London; Katherine A McGlynn
Journal:  Cancer Prev Res (Phila)       Date:  2012-08

10.  Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C.

Authors:  Miyuki Miyashita; Takayoshi Ito; Masashi Sakaki; Atsushi Kajiwara; Hisako Nozawa; Kazumasa Hiroishi; Mariko Kobayashi; Hiromitsu Kumada; Michio Imawari
Journal:  J Viral Hepat       Date:  2012-01-28       Impact factor: 3.728
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.